This impurity is related to Buprenorphine EP Impurity G is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Buprenorphine EP Impurity G is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(4R,4'R,5S,5'S,7R,7'R,8R,8'R,9R,9'R,17S,17'S)-3,3'-bis(cyclopropylmethyl)-7,7'-bis((S)-2-hydroxy-3,3-dimethylbutan-2-yl)-8,8'-dimethoxy-2,2',3,3',4,4',6,6',7,7',8,8',9,9',18,18',19,19',20,20'-icosahydro-1H,1'H-[13,13'-bi(4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinoline)]-12,12'-diolCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Buprenorphine Molecular Formula: C58H80N2O8
Molecular Weight: 933.3
Storage: Store in a cool, dry place.